Kaplan-Meier curves showing overall survival of patients with NAMPT+ (blue line) and NAMPT- (red line) PDA. Median OS: 20.4 months (NAMPT+) vs. 26.0 months (NAMPT-); P-value: 0.34.</p
Sarcopenia diminishes overall survival in patients with resectable PDAC (14 vs. 20 months, p = 0.016...
<p>(A) Kaplan-Meier (KM) survival curves at the 120-month follow up point (TFU). (B) Kaplan-Meier me...
Kaplan-Meier curves for biochemical progression-free survival of all patients stratified according t...
Kaplan-Meier curves showing recurrence-free survival of patients with NAMPT+ (blue line) and NAMPT- ...
<p>The overall survival of patients with NK-AML (solid line) and CK-AML (dotted line) analyzed by th...
<p>(A) Kaplan-Meier survival curves of patients with survivin mRNA above (black squares) or under th...
<p>Data on 5-years Overall Survival and Trend test are shown according to each staging system for HP...
(a) Progression-free survival and (b) overall survival for patients with more than 70% reduction in ...
<p>(A) Overall survival. (B) Progression-free survival. (C) Locoregional relapse-free survival and (...
<p>Kaplan-Meier analysis to plot the survival curve of all 272 NPC patients with expression of p-Mnk...
<p>Kaplan-Meier plots of overall survival in patients without PVTT (A) and in patients with PVTT (B)...
<p>Kaplan-Meier overall survival curves for NSTE-ACS patients according to normal and low LVEF.</p
<p>Kaplan-Meier curves showing overall survival (A) and progression free survival (B) with 95% confi...
<p>A) Overall survival of patients with high (>6.7; grey) or low (<6.7; red) baseline SUVmax in FDG-...
<p>Data on 5-years Overall Survival and Trend test are shown according to each staging system for HP...
Sarcopenia diminishes overall survival in patients with resectable PDAC (14 vs. 20 months, p = 0.016...
<p>(A) Kaplan-Meier (KM) survival curves at the 120-month follow up point (TFU). (B) Kaplan-Meier me...
Kaplan-Meier curves for biochemical progression-free survival of all patients stratified according t...
Kaplan-Meier curves showing recurrence-free survival of patients with NAMPT+ (blue line) and NAMPT- ...
<p>The overall survival of patients with NK-AML (solid line) and CK-AML (dotted line) analyzed by th...
<p>(A) Kaplan-Meier survival curves of patients with survivin mRNA above (black squares) or under th...
<p>Data on 5-years Overall Survival and Trend test are shown according to each staging system for HP...
(a) Progression-free survival and (b) overall survival for patients with more than 70% reduction in ...
<p>(A) Overall survival. (B) Progression-free survival. (C) Locoregional relapse-free survival and (...
<p>Kaplan-Meier analysis to plot the survival curve of all 272 NPC patients with expression of p-Mnk...
<p>Kaplan-Meier plots of overall survival in patients without PVTT (A) and in patients with PVTT (B)...
<p>Kaplan-Meier overall survival curves for NSTE-ACS patients according to normal and low LVEF.</p
<p>Kaplan-Meier curves showing overall survival (A) and progression free survival (B) with 95% confi...
<p>A) Overall survival of patients with high (>6.7; grey) or low (<6.7; red) baseline SUVmax in FDG-...
<p>Data on 5-years Overall Survival and Trend test are shown according to each staging system for HP...
Sarcopenia diminishes overall survival in patients with resectable PDAC (14 vs. 20 months, p = 0.016...
<p>(A) Kaplan-Meier (KM) survival curves at the 120-month follow up point (TFU). (B) Kaplan-Meier me...
Kaplan-Meier curves for biochemical progression-free survival of all patients stratified according t...